1-50 of 108
Keywords: Breast cancer
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles
Biosci Rep (2025) 45 (03): BSR20241173.
Published: 14 March 2025
... underline the importance of aromatic interactions. The L35P (c.104T > C) mutation was identified from a breast cancer family, a loss of function mutation that disrupts PALB2–BRCA1 interaction [ 18 ]. Our MD simulations on the PALB2cc structure suggest the mutation completely disrupts the helical...
Includes: Supplementary data
Articles
Articles
Articles
Articles
Articles
Articles
Articles
Articles
Biosci Rep (2023) 43 (2): BSR-2019-2298_RET.
Published: 10 February 2023
... © 2023 The Author(s). 2023 This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY) . Breast cancer FOXA2 MicroRNA-942 Prognosis Progression...
Articles
Articles
Articles
Articles
Articles
Articles
Biosci Rep (2022) 42 (7): BSR-2019-1611_RET.
Published: 27 July 2022
... the article. The Editor-in-Chief and Editorial Board agree with the Retraction. AKT3 breast cancer metastasis miRNA NF-κB © 2022 The Author(s). 2022 This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative...
Articles
Articles
Biosci Rep (2022) 42 (2): BSR20212035.
Published: 04 February 2022
...Yao Song; Meiling Lu; Lijin Feng; Qian Chen; Hua Huang; Qing Lin Breast cancer is a serious malignancy with a high incidence worldwide and a tendency to relapse. We used integrated bioinformatics analysis to identify potential biomarkers in breast carcinoma in the present study. Microarray data...
Includes: Supplementary data
Articles
Articles
Biosci Rep (2021) 41 (10): BSR20211123.
Published: 19 October 2021
...Ying Jing; Donghai Li MicroRNAs (miRNAs) play important roles in a variety of human diseases, including breast cancer. A number of miRNAs are up- and down-regulated in breast cancer. However, little is known about miRNA similarity and similarity network in breast cancer. Here, a collection of 272...
Includes: Supplementary data
Articles
Articles
Biosci Rep (2021) 41 (7): BSR-2019-0787_RET.
Published: 28 July 2021
... © 2021 The Author(s). 2021 This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY) . Breast cancer miR-326 proliferation SOX12 This article is being...
Articles
Articles
Biosci Rep (2021) 41 (4): BSR20210034.
Published: 27 April 2021
.... Radiosensitive gene/biomarker can be useful for predicting which patients would benefit from radiotherapy. The discovery of radiosensitivity biomarkers require multiple pieces of evidence. A prediction model of breast cancer radiosensitivity based on six genes was established. We had put forward some supplements...
Articles
Articles
Articles
Articles
Articles
Articles
Articles
Articles
Biosci Rep (2021) 41 (1): BSR20203481.
Published: 27 January 2021
...Li-rong Yan; Ang Wang; Zhi Lv; Yuan Yuan; Qian Xu Background: Mitochondria-nuclear cross-talk and mitochondrial retrograde regulation are involved in the genesis and development of breast cancer (BC). Therefore, mitochondria can be regarded as a promising target for BC therapeutic strategies...
Includes: Supplementary data
Articles
Articles
Biosci Rep (2020) 40 (12): BSR20201215.
Published: 10 December 2020
... function of miR-1298 in cancers, however, the regulatory mechanism of miR-1298 in breast cancer (BC) remains unclear. Here, our findings showed that miR-1298 was down-regulated in BC tissues and cell lines. Lower level of miR-1298 was significantly correlated with the advanced progression of BC patients...
Articles
Biosci Rep (2020) 40 (12): BSR20202376.
Published: 02 December 2020
...Xing Chen; Junjie Zheng; Min ling Zhuo; Ailong Zhang; Zhenhui You Breast cancer (BRCA) represents the most common malignancy among women worldwide with high mortality. Radiotherapy is a prevalent therapeutic for BRCA that with heterogeneous effectiveness among patients. Here, we proposed to develop...
Includes: Supplementary data
Articles
Biosci Rep (2020) 40 (11): BSR20200115.
Published: 25 November 2020
... health after NPs exposure. Objective: Green synthesis of gold NPs (AuNPs) and assessment of their activity in 7,12-dimethylbenz(a)anthracene (DMBA)-induced breast cancer mouse model. Methods: Chloroauric acid (HAuCl 4 ) was used in formation of AuNPs with the help of Curcuma longa as aqueous reducing...
Articles
Articles
Articles
Articles
Articles
Biosci Rep (2020) 40 (9): BSR20202537.
Published: 10 September 2020
... of the association between PITX1 expression and the survival in breast cancer remains unclear. Methods: Clinical prognostic parameters and survival data related to PITX1 in breast cancer patients were performed using the bioinformatic analysis including Oncomine, Bc-GenExMiner v4.3, PrognoScan and UCSC Xena. Results...
Articles
Articles
Articles
Biosci Rep (2020) 40 (8): BSR20200764.
Published: 13 August 2020
...Limei Liu; Jiaomin Yang; Chao Wang Background: Breast cancer (BC) is the most common malignancy in females and remains a main cause of cancer-associated death worldwide. The solute carrier (SLC) groups of membrane transport proteins, which control the influx of zinc, participate in ranging...
Includes: Supplementary data
Articles
Biosci Rep (2020) 40 (8): BSR20201648.
Published: 11 August 2020
...Min Zhang; Jin Zhang Background: Breast cancer is the second most common malignancy in women and considered as a severe health burden. PEG3 mutations have been observed in several cancers. However, the associations of PEG3 mutation with tumor mutation burden (TMB) and prognosis in breast cancer...
Includes: Supplementary data
Articles
Biosci Rep (2020) 40 (7): BSR20201054.
Published: 07 July 2020
...Jun Fang; Feng Chen; Dong Liu; Feiying Gu; Zhigang Chen; Yuezhen Wang Immune checkpoint blockade treatments bring remarkable clinical benefits to fighting several solid malignancies. However, the efficacy of immune checkpoint blockade in breast cancer remains controversial. Several clinical trials...
Includes: Supplementary data
Articles
Articles
Articles
Articles
Biosci Rep (2020) 40 (5): BSR20191227.
Published: 05 May 2020
... in breast cancer are seldom reported till now, most of which are not systematic and conclusive. The present study was performed to analyze the expression pattern, potential function, and distinct prognostic effect of CDC20 in breast cancer using several online databases including Oncomine, bc-GenExMiner...
Articles